Fundraising Fox
Onechaintx
1 known investors
Find your way into Onechaintx
Sign up to see every warm intro you have to Onechaintx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Onechaintx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
Founders & leadership
PM
Pablo MenéndezScientific Founder
Investors · 1
Frequently asked questions
- What does Onechaintx do?
- OneChain Immunotherapeutics is a clinical-stage biotech developing CAR-T cell therapy candidates as treatments for oncological diseases. It is a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, based on research led by Dr. Pablo Menéndez's team.
- Who founded Onechaintx?
- Onechaintx was founded by Pablo Menéndez.
- Who are Onechaintx's investors?
- Onechaintx's investors include Invivo Capital Partners.